Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congenital heart disease (CHD) is the most common class of human birth defects, with a prevalence of 0.9% of births. However, two-thirds of cases have an unknown cause, and many of these are thought to be caused by in utero exposure to environmental teratogens. Here we identify a potential teratogen causing CHD in mice: maternal iron deficiency (ID). We show that maternal ID in mice causes severe cardiovascular defects in the offspring. These defects likely arise from increased retinoic acid signalling in ID embryos. The defects can be prevented by iron administration in early pregnancy. It has also been proposed that teratogen exposure may potentiate the effects of genetic predisposition to CHD through gene-environment interaction. Here we show that maternal ID increases the severity of heart and craniofacial defects in a mouse model of Down syndrome. It will be important to understand if the effects of maternal ID seen here in mice may have clinical implications for women.

Original publication

DOI

10.1038/s41467-021-23660-5

Type

Journal article

Journal

Nat Commun

Publication Date

08/06/2021

Volume

12

Keywords

Animals, Aorta, Thoracic, Biomarkers, Cardiovascular System, Cell Differentiation, Coronary Vessels, Dietary Supplements, Edema, Embryo, Mammalian, Embryonic Development, Female, Gene Expression Profiling, Gene-Environment Interaction, Green Fluorescent Proteins, Iron, Iron Deficiencies, Lymphatic Vessels, Mice, Inbred C57BL, Myocardium, Myocytes, Cardiac, Penetrance, Phenotype, Pregnancy, Signal Transduction, Stem Cells, Transgenes, Tretinoin